Literature DB >> 32809973

EBV-induced gene 3 augments IL-23Rα protein expression through a chaperone calnexin.

Izuru Mizoguchi1, Mio Ohashi1, Hideaki Hasegawa1, Yukino Chiba1, Naoko Orii1, Shinya Inoue1, Chiaki Kawana1, Mingli Xu1, Katsuko Sudo2, Koji Fujita3, Masahiko Kuroda3, Shin-Ichi Hashimoto4, Kouji Matsushima5, Takayuki Yoshimoto1.   

Abstract

Epstein-Barr virus-induced gene 3 (EBI3) is a subunit common to IL-27, IL-35, and IL-39. Here, we explore an intracellular role of EBI3 that is independent of its function in cytokines. EBI3-deficient naive CD4+ T cells had reduced IFN-γ production and failed to induce T cell-dependent colitis in mice. Similarly reduced IFN-γ production was observed in vitro in EBI3-deficient CD4+ T cells differentiated under pathogenic Th17 polarizing conditions with IL-23. This is because the induction of expression of one of the IL-23 receptor (IL-23R) subunits, IL-23Rα, but not another IL-23R subunit, IL-12Rβ1, was selectively decreased at the protein level, but not the mRNA level. EBI3 augmented IL-23Rα expression via binding to the chaperone molecule calnexin and to IL-23Rα in a peptide-dependent manner, but not a glycan-dependent manner. Indeed, EBI3 failed to augment IL-23Rα expression in the absence of endogenous calnexin. Moreover, EBI3 poorly augmented the expression of G149R, an IL-23Rα variant that protects against the development of human colitis, because binding of EBI3 to the variant was reduced. Taken together with the result that EBI3 expression is inducible in T cells, the present results suggest that EBI3 plays a critical role in augmenting IL-23Rα protein expression via calnexin under inflammatory conditions.

Entities:  

Keywords:  Chaperones; Cytokines; Immunology; Inflammation

Year:  2020        PMID: 32809973      PMCID: PMC7598073          DOI: 10.1172/JCI122732

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

1.  Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas.

Authors:  F Larousserie; E Bardel; A Coulomb L'Herminé; D Canioni; N Brousse; R A Kastelein; O Devergne
Journal:  J Pathol       Date:  2006-07       Impact factor: 7.996

2.  Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.

Authors:  Thomas Gehlert; Odile Devergne; Gerald Niedobitek
Journal:  J Med Virol       Date:  2004-07       Impact factor: 2.327

Review 3.  Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation.

Authors:  Robert A Kastelein; Christopher A Hunter; Daniel J Cua
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 4.  Unravelling the pathogenesis of inflammatory bowel disease.

Authors:  R J Xavier; D K Podolsky
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

5.  Ebi3 promotes T- and B-cell division and differentiation via STAT3.

Authors:  Ning Ma; Ying Fang; Ruonan Xu; Bing Zhai; Chunmei Hou; Xiaoqian Wang; Zhenyu Jiang; Liang Wang; Qilin Liu; Gencheng Han; Renxi Wang
Journal:  Mol Immunol       Date:  2019-01-17       Impact factor: 4.407

6.  The IL-12 p40 homodimer as a specific antagonist of the IL-12 heterodimer.

Authors:  T Germann; E Rüde; F Mattner; M K Gately
Journal:  Immunol Today       Date:  1995-10

7.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

8.  Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.

Authors:  Charles O Elson; Yingzi Cong; Casey T Weaver; Trenton R Schoeb; Terrill K McClanahan; Robert B Fick; Robert A Kastelein
Journal:  Gastroenterology       Date:  2007-04-13       Impact factor: 22.682

9.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

10.  Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Julie Gonin; Frédérique Larousserie; Christian Bastard; Jean-Michel Picquenot; Jérôme Couturier; Isabelle Radford-Weiss; Céline Dietrich; Nicole Brousse; Marie-Cécile Vacher-Lavenu; Odile Devergne
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

View more
  2 in total

Review 1.  Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus.

Authors:  Neelakshi R Jog; Judith A James
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

Review 2.  A Chaperone-Like Role for EBI3 in Collaboration With Calnexin Under Inflammatory Conditions.

Authors:  Aruma Watanabe; Izuru Mizoguchi; Hideaki Hasegawa; Yasuhiro Katahira; Shinya Inoue; Eri Sakamoto; Yuma Furusaka; Ami Sekine; Satomi Miyakawa; Fumihiro Murakami; Mingli Xu; Toshihiko Yoneto; Takayuki Yoshimoto
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.